Gareth Whitaker is our Senior Director, Pharmacokinetics and Scintigraphy. He has over 18 years of experience in early phase drug development, supporting PK analysis and reporting across >400 pre-clinical / early phase clinical studies, investigating single and multiple ascending doses, formulation development and optimisation, ADME, IV micro tracer, bioequivalence, relative bioavailability, drug-drug interaction, and PK/PD, across numerous therapeutic areas. His contributions provide expert biopharmaceutic support to early drug development and clinical program design.

Gareth holds a Bachelor of Science degree in Pharmacology and Neuroscience from Nottingham Trent University.